Search - tctmd.com

Displaying 81 - 94 of 94

Presentation TCT 2013

Clinical Outcome Of Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation.

Presenter: Jury Schewel, Dimitry Schewel, Christian Frerker, Thomas Thielsen, Felix Meinke, Felix Kreidel, Karl-Heinz Kuck, Ulrich Sch?fer

January 31, 2013

Presentation TCT 2013

Clinical Outcome Of Patients With Low-Flow, Low-Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation.

Presenter: Jury Schewel, Dimitry Schewel, Christian Frerker, Thomas Thielsen, Felix Meinke, Felix Kreidel, Karl-Heinz Kuck, Ulrich Sch?fer

January 31, 2013

Presentation TCT 2013

Clinical Impact Of Paravalvular Leaks On Biomarkers And Survival After Transcatheter Aortic Valve Implantation.

Presenter: Dimitry Schewel, Christian Frerker, Jury Schewel, Felix Meinke, Thomas Thielsen, Klaus Blaschke, Felix Kreidel, Karl-Heinz Kuck, Ulrich Sch?fer

January 31, 2013

Presentation TCT 2013

Acute assessment of transcatheter aortic valve performance after implantation into degenerated aortic surgical bioprostheses

Presenter: Ulrich Sch?fer, Christian Frerker, Dimitry Schewel, Thomas Thielsen, Felix Kreidel, Karl-Heinz Kuck

January 31, 2013

Presentation TCT 2012

Paradise (ReCor)

Presenter: Karl-Heinz Kuck

October 24, 2012

Presentation TCT 2012

A Novel Self-Expanding TAVR System: CENTERA

Presenter: Karl-Heinz Kuck

October 24, 2012

Presentation TCT 2012

RESHAPE

Presenter: Karl-Heinz Kuck

October 23, 2012

News Industry News

Medtronic Receives FDA Approval, CE Mark for Arctic Front Advance™ Cardiac Cryoballoon to Treat Atrial Fibrillation

August 24, 2012

Presentation TVT 2012

Pitfalls and Complications of Transseptal Puncture

Presenter: Karl-Heinz Kuck

June 05, 2012

Presentation TVT 2012

Direct Annuloplasty in Evolution 3: ReCor

Presenter: Karl-Heinz Kuck

June 04, 2012

Presentation TVT 2012

Design and Function/Clinical Outcomes - CENTERA

Presenter: Karl-Heinz Kuck

June 03, 2012

Presentation TVT 2012

Attributes of the CENTERA Self-Expanding TAVR System

Presenter: Karl-Heinz Kuck

June 03, 2012

News Industry News

First Patient Enrolled in Medtronic-Supported Head-To-Head Clinical Trial Comparing Cryoballoon Ablation to RF Ablation for Paroxysmal Atrial Fibrillation

January 23, 2012

News Industry News

Advanced Cardiac Therapeutics Initiates First-In-Man CE Mark Clinical Trial to Study Innovative Catheter System for the Treatment of Atrial Arrhythmias

March 17, 2011

Advertisement

Clinical Outcome Of Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation.

Clinical Outcome Of Patients With Low-Flow, Low-Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation.

Clinical Impact Of Paravalvular Leaks On Biomarkers And Survival After Transcatheter Aortic Valve Implantation.

Acute assessment of transcatheter aortic valve performance after implantation into degenerated aortic surgical bioprostheses

Paradise (ReCor)

A Novel Self-Expanding TAVR System: CENTERA

RESHAPE

Medtronic Receives FDA Approval, CE Mark for Arctic Front Advance™ Cardiac Cryoballoon to Treat Atrial Fibrillation

Pitfalls and Complications of Transseptal Puncture

Direct Annuloplasty in Evolution 3: ReCor

Design and Function/Clinical Outcomes - CENTERA

Attributes of the CENTERA Self-Expanding TAVR System

First Patient Enrolled in Medtronic-Supported Head-To-Head Clinical Trial Comparing Cryoballoon Ablation to RF Ablation for Paroxysmal Atrial Fibrillation

Advanced Cardiac Therapeutics Initiates First-In-Man CE Mark Clinical Trial to Study Innovative Catheter System for the Treatment of Atrial Arrhythmias

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content